Software - Application
Compare Stocks
5 / 10Stock Comparison
AMOD vs PERI vs MGNI vs CDLX vs TPVG
Revenue, margins, valuation, and 5-year total return — side by side.
Internet Content & Information
Advertising Agencies
Advertising Agencies
Asset Management
AMOD vs PERI vs MGNI vs CDLX vs TPVG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Internet Content & Information | Advertising Agencies | Advertising Agencies | Asset Management |
| Market Cap | $1M | $483M | $2.01B | $43M | $243M |
| Revenue (TTM) | $0.00 | $440M | $723M | $206M | $97M |
| Net Income (TTM) | $-7M | $-8M | $159M | $-95M | $-12M |
| Gross Margin | — | 33.3% | 63.4% | 38.9% | 83.5% |
| Operating Margin | — | -3.4% | 14.8% | -22.8% | 77.9% |
| Forward P/E | 0.3x | 8.9x | 13.4x | — | 6.5x |
| Total Debt | $5M | $42M | $279M | $215M | $469M |
| Cash & Equiv. | $736K | $91M | $553M | $49M | $20M |
AMOD vs PERI vs MGNI vs CDLX vs TPVG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Dec 24 | May 26 | Return |
|---|---|---|---|
| Alpha Modus Holding… (AMOD) | 100 | 7.7 | -92.3% |
| Perion Network Ltd. (PERI) | 100 | 127.3 | +27.3% |
| Magnite, Inc. (MGNI) | 100 | 87.9 | -12.1% |
| Cardlytics, Inc. (CDLX) | 100 | 21.1 | -78.9% |
| TriplePoint Venture… (TPVG) | 100 | 81.2 | -18.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AMOD vs PERI vs MGNI vs CDLX vs TPVG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AMOD is the #2 pick in this set and the best alternative if value is your priority.
- Lower P/E (0.3x vs 6.5x)
PERI is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 0 yrs, beta 0.94
- 139.6% 10Y total return vs TPVG's 93.3%
- Lower volatility, beta 0.94, Low D/E 6.3%, current ratio 2.76x
- Beta 0.94, current ratio 2.76x
MGNI ranks third and is worth considering specifically for growth exposure.
- Rev growth 6.9%, EPS growth 493.8%, 3Y rev CAGR 7.4%
- 5.3% ROA vs AMOD's -18.2%
Among these 5 stocks, CDLX doesn't own a clear edge in any measured category.
TPVG carries the broadest edge in this set and is the clearest fit for growth and quality.
- 36.6% NII/revenue growth vs AMOD's -8.4%
- 50.6% margin vs CDLX's -46.0%
- Beta 0.83 vs CDLX's 3.18
- 17.1% yield; the other 4 pay no meaningful dividend
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 36.6% NII/revenue growth vs AMOD's -8.4% | |
| Value | Lower P/E (0.3x vs 6.5x) | |
| Quality / Margins | 50.6% margin vs CDLX's -46.0% | |
| Stability / Safety | Beta 0.83 vs CDLX's 3.18 | |
| Dividends | 17.1% yield; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +19.3% vs AMOD's -82.3% | |
| Efficiency (ROA) | 5.3% ROA vs AMOD's -18.2% |
AMOD vs PERI vs MGNI vs CDLX vs TPVG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
AMOD vs PERI vs MGNI vs CDLX vs TPVG — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
TPVG leads in 1 of 6 categories
MGNI leads 1 • AMOD leads 0 • PERI leads 0 • CDLX leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
TPVG leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MGNI and AMOD operate at a comparable scale, with $723M and $0 in trailing revenue. TPVG is the more profitable business, keeping 50.6% of every revenue dollar as net income compared to CDLX's -46.0%. On growth, PERI holds the edge at +5.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $0 | $440M | $723M | $206M | $97M |
| EBITDAEarnings before interest/tax | -$4M | $3M | $145M | -$23M | -$22M |
| Net IncomeAfter-tax profit | -$7M | -$8M | $159M | -$95M | -$12M |
| Free Cash FlowCash after capex | -$2M | $39M | $44M | $6M | $35M |
| Gross MarginGross profit ÷ Revenue | — | +33.3% | +63.4% | +38.9% | +83.5% |
| Operating MarginEBIT ÷ Revenue | — | -3.4% | +14.8% | -22.8% | +77.9% |
| Net MarginNet income ÷ Revenue | — | -1.8% | +22.0% | -46.0% | +50.6% |
| FCF MarginFCF ÷ Revenue | — | +8.9% | +6.1% | +2.9% | -58.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +5.8% | +5.5% | -44.6% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -176.2% | +72.7% | +142.9% | +3.8% | -2.3% |
Valuation Metrics
Evenly matched — PERI and CDLX each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 0.3x trailing earnings, AMOD trades at a 98% valuation discount to MGNI's 14.7x P/E. On an enterprise value basis, AMOD's 1.3x EV/EBITDA is more attractive than PERI's 106.0x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1M | $483M | $2.0B | $43M | $243M |
| Enterprise ValueMkt cap + debt − cash | $6M | $434M | $1.7B | $210M | $691M |
| Trailing P/EPrice ÷ TTM EPS | 0.32x | -56.74x | 14.74x | -0.40x | 4.91x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 8.89x | 13.45x | — | 6.50x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 4.84x |
| EV / EBITDAEnterprise value multiple | 1.30x | 106.04x | 11.43x | — | 9.13x |
| Price / SalesMarket cap ÷ Revenue | — | 1.10x | 2.81x | 0.18x | 2.50x |
| Price / BookPrice ÷ Book value/share | — | 0.67x | 2.33x | — | 0.68x |
| Price / FCFMarket cap ÷ FCF | — | 12.66x | 12.11x | 4.89x | — |
Profitability & Efficiency
MGNI leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
MGNI delivers a 18.6% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $-9 for CDLX. PERI carries lower financial leverage with a 0.06x debt-to-equity ratio, signaling a more conservative balance sheet compared to TPVG's 1.33x. On the Piotroski fundamental quality scale (0–9), MGNI scores 6/9 vs PERI's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | — | -1.2% | +18.6% | -8.7% | -3.4% |
| ROA (TTM)Return on assets | -18.2% | -0.9% | +5.3% | -31.5% | -1.5% |
| ROICReturn on invested capital | — | -1.7% | +9.5% | -18.3% | +7.2% |
| ROCEReturn on capital employed | — | -1.8% | +7.3% | -20.9% | +9.4% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 3 | 6 | 6 | 5 |
| Debt / EquityFinancial leverage | — | 0.06x | 0.30x | — | 1.33x |
| Net DebtTotal debt minus cash | $4M | -$49M | -$275M | $167M | $449M |
| Cash & Equiv.Liquid assets | $735,814 | $91M | $553M | $49M | $20M |
| Total DebtShort + long-term debt | $5M | $42M | $279M | $215M | $469M |
| Interest CoverageEBIT ÷ Interest expense | -1.09x | — | 4.03x | -14.37x | -1.02x |
Total Returns (Dividends Reinvested)
Evenly matched — PERI and MGNI and TPVG each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in TPVG five years ago would be worth $8,649 today (with dividends reinvested), compared to $78 for CDLX. Over the past 12 months, TPVG leads with a +19.3% total return vs AMOD's -82.3%. The 3-year compound annual growth rate (CAGR) favors MGNI at 16.7% vs AMOD's -71.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -50.2% | +15.3% | -12.8% | -30.2% | -6.3% |
| 1-Year ReturnPast 12 months | -82.3% | +16.9% | +12.6% | -63.8% | +19.3% |
| 3-Year ReturnCumulative with dividends | -97.8% | -68.0% | +58.7% | -86.5% | -3.4% |
| 5-Year ReturnCumulative with dividends | -97.8% | -37.2% | -60.9% | -99.2% | -13.5% |
| 10-Year ReturnCumulative with dividends | -97.8% | +139.6% | -4.7% | -94.2% | +93.3% |
| CAGR (3Y)Annualised 3-year return | -71.9% | -31.6% | +16.7% | -48.8% | -1.2% |
Risk & Volatility
Evenly matched — PERI and TPVG each lead in 1 of 2 comparable metrics.
Risk & Volatility
TPVG is the less volatile stock with a 0.83 beta — it tends to amplify market swings less than CDLX's 3.18 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PERI currently trades 91.4% from its 52-week high vs AMOD's 8.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.51x | 0.94x | 1.63x | 3.18x | 0.83x |
| 52-Week HighHighest price in past year | $2.60 | $11.79 | $26.65 | $3.28 | $7.53 |
| 52-Week LowLowest price in past year | $0.20 | $8.07 | $10.82 | $0.66 | $4.48 |
| % of 52W HighCurrent price vs 52-week peak | +8.8% | +91.4% | +52.5% | +23.8% | +79.5% |
| RSI (14)Momentum oscillator 0–100 | 26.0 | 59.1 | 55.4 | 36.6 | 58.3 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 321K | 2.1M | 1.2M | 504K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: PERI as "Buy", MGNI as "Buy", TPVG as "Hold". Consensus price targets imply 49.4% upside for TPVG (target: $9) vs 28.6% for MGNI (target: $18). TPVG is the only dividend payer here at 17.11% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | — | Hold |
| Price TargetConsensus 12-month target | — | $14.00 | $18.00 | — | $8.95 |
| # AnalystsCovering analysts | — | 13 | 31 | — | 12 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | +17.1% |
| Dividend StreakConsecutive years of raises | — | 0 | — | — | 0 |
| Dividend / ShareAnnual DPS | — | — | — | — | $1.02 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +14.7% | +2.3% | 0.0% | 0.0% |
TPVG leads in 1 of 6 categories (Income & Cash Flow). MGNI leads in 1 (Profitability & Efficiency). 3 tied.
AMOD vs PERI vs MGNI vs CDLX vs TPVG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AMOD or PERI or MGNI or CDLX or TPVG a better buy right now?
For growth investors, TriplePoint Venture Growth BDC Corp.
(TPVG) is the stronger pick with 36. 6% revenue growth year-over-year, versus -16. 2% for Cardlytics, Inc. (CDLX). Alpha Modus Holdings, Inc. (AMOD) offers the better valuation at 0. 3x trailing P/E, making it the more compelling value choice. Analysts rate Perion Network Ltd. (PERI) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AMOD or PERI or MGNI or CDLX or TPVG?
On trailing P/E, Alpha Modus Holdings, Inc.
(AMOD) is the cheapest at 0. 3x versus Magnite, Inc. at 14. 7x. On forward P/E, TriplePoint Venture Growth BDC Corp. is actually cheaper at 6. 5x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — AMOD or PERI or MGNI or CDLX or TPVG?
Over the past 5 years, TriplePoint Venture Growth BDC Corp.
(TPVG) delivered a total return of -13. 5%, compared to -99. 2% for Cardlytics, Inc. (CDLX). Over 10 years, the gap is even starker: PERI returned +139. 6% versus AMOD's -97. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AMOD or PERI or MGNI or CDLX or TPVG?
By beta (market sensitivity over 5 years), TriplePoint Venture Growth BDC Corp.
(TPVG) is the lower-risk stock at 0. 83β versus Cardlytics, Inc. 's 3. 18β — meaning CDLX is approximately 283% more volatile than TPVG relative to the S&P 500. On balance sheet safety, Perion Network Ltd. (PERI) carries a lower debt/equity ratio of 6% versus 133% for TriplePoint Venture Growth BDC Corp. — giving it more financial flexibility in a downturn.
05Which is growing faster — AMOD or PERI or MGNI or CDLX or TPVG?
By revenue growth (latest reported year), TriplePoint Venture Growth BDC Corp.
(TPVG) is pulling ahead at 36. 6% versus -16. 2% for Cardlytics, Inc. (CDLX). On earnings-per-share growth, the picture is similar: Alpha Modus Holdings, Inc. grew EPS 20. 3% year-over-year, compared to -176. 0% for Perion Network Ltd.. Over a 3-year CAGR, MGNI leads at 7. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AMOD or PERI or MGNI or CDLX or TPVG?
TriplePoint Venture Growth BDC Corp.
(TPVG) is the more profitable company, earning 50. 6% net margin versus -44. 4% for Cardlytics, Inc. — meaning it keeps 50. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TPVG leads at 77. 9% versus -20. 2% for CDLX. At the gross margin level — before operating expenses — TPVG leads at 83. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AMOD or PERI or MGNI or CDLX or TPVG more undervalued right now?
On forward earnings alone, TriplePoint Venture Growth BDC Corp.
(TPVG) trades at 6. 5x forward P/E versus 13. 4x for Magnite, Inc. — 7. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TPVG: 49. 4% to $8. 95.
08Which pays a better dividend — AMOD or PERI or MGNI or CDLX or TPVG?
In this comparison, TPVG (17.
1% yield) pays a dividend. AMOD, PERI, MGNI, CDLX do not pay a meaningful dividend and should not be held primarily for income.
09Is AMOD or PERI or MGNI or CDLX or TPVG better for a retirement portfolio?
For long-horizon retirement investors, TriplePoint Venture Growth BDC Corp.
(TPVG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 83), 17. 1% yield). Cardlytics, Inc. (CDLX) carries a higher beta of 3. 18 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (TPVG: +93. 3%, CDLX: -94. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AMOD and PERI and MGNI and CDLX and TPVG?
These companies operate in different sectors (AMOD (Technology) and PERI (Communication Services) and MGNI (Communication Services) and CDLX (Communication Services) and TPVG (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: AMOD is a small-cap deep-value stock; PERI is a small-cap quality compounder stock; MGNI is a small-cap deep-value stock; CDLX is a small-cap quality compounder stock; TPVG is a small-cap high-growth stock. TPVG pays a dividend while AMOD, PERI, MGNI, CDLX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Communication Services
- Market Cap > $100B
- Revenue Growth > 5%
- Gross Margin > 20%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.